Standout Papers

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Ca... 1998 2026 2007 2016 812
  1. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial (2009)
    Ian M. Thompson, Catherine M. Tangen et al. The Journal of Urology
  2. Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer (1998)
    Mario A. Eisenberger, Brent A. Blumenstein et al. New England Journal of Medicine
  3. Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer (2006)
    Ian M. Thompson, Catherine M. Tangen et al. JAMA
  4. Molecular characterization of human prostate carcinoma cell lines (2003)
    Adrie van Bokhoven, Marileila Varella‐Garcia et al. The Prostate

Immediate Impact

12 by Nobel laureates 10 from Science/Nature 63 standout
Sub-graph 1 of 17

Citing Papers

Prostate cancer
2021 Standout
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
46 intermediate papers

Works of Gary J. Miller being referenced

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
2009 Standout
Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific Markers
1999
and 8 more

Author Peers

Author Last Decade Papers Cites
Gary J. Miller 4480 2568 1328 1620 226 12.2k
David R. Phillips 4024 4324 2310 650 474 27.1k
Roberto D’Amico 1652 845 2342 1409 222 21.0k
Sydney Finkelstein 1878 2256 1863 210 254 23.7k
David Owen 1347 2172 1866 773 384 8.9k
Robert W. Jackman 646 4383 516 2343 100 11.2k
Moshe Maor 6511 909 4088 546 196 13.5k
Fred R. Hirsch 10106 6132 1467 353 371 20.9k
Andrew R. Green 2366 10396 1069 1142 580 25.6k
Bob S. Carter 3632 10610 1505 284 320 22.3k
Richard Sullivan 1643 2308 981 97 442 14.7k

All Works

Loading papers...

Rankless by CCL
2026